Skip to main content

Loading market ticker...

Bafna Pharma

Healthcare NSE:BAFNAPH

174.58INR
-19.39 ( -10.00%)

Last update at June 9, 2026, midnight

Day Range

174.58213.36
LowHigh

52 Week Range

69.00 202.06
LowHigh

Fundamentals

  • Previous Close 193.97
  • Market Cap 3295.33M
  • Volume283,731
  • P/E Ratio 37.55
  • EBITDA 160.37M
  • Revenue TTM 1423.40M
  • Revenue Per Share TTM 60.16
  • Gross Profit TTM 462.74M
  • Diluted EPS TTM 3.71

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1427.60 15/05/26 15/05/26 Same Day Short Term Healthcare 0.17%
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 41.53M 73.48M 116.16M 52.16M 58.27M
Net income 41.53M 73.48M 113.38M 52.16M 58.27M
Total Revenue 1458.57M 1524.66M 1153.50M 851.40M 712.18M
Gross Profit 168.77M 452.15M 387.56M 338.60M 257.62M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 1530.79M 1476.82M 1295.83M 902.44M 864.66M
Intangible assets - 17.70M 15.00M 15.00M -
Other current assets 130.12M 180.37M 156.05M 161.66M 228.62M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 20.37M -64.13M 76.36M -16.31M -66.76M
Operating Cash 195.29M 94.85M 49.53M 97.28M -136.09M
Free Cash Flow -23.31M -60.93M -32.66M 21.87M -197.04M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
BAFNAPH
Bafna Pharma 		-19.39 -10.00% 174.58 3295.33 37.55
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-9.80 -0.55% 1779.00 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		232.00 3.56% 6753.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		62.50 1.42% 4472.90 1362716.66 63.48
CIPLA
Cipla Limited 		-11.40 -0.82% 1376.50 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.